DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

Selected Abstracts from CNS Summit 2025

Innov Clin Neur. 2025;22(10–12):78–85. November 2–5, 2025 in Boston, Massachusetts. Artificial intelligence (AI)/machine-based learning Digital phenotyping with real-world data to identify candidates for anti-CGRP migraine treatment Presenters: Giorgio Pietro Biondetti;

Risk Management: I’ve Been Sued, Now What! Part 4: Closing Statements, Jury Deliberations, Verdicts, Judgments, and Appeals

Innov Clin Neurosci. 2025;22(10–12):86–87. by Justin Pope, JD Mr. Pope is Associate Director of Risk Management at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation

“You’re Not Crazy”: A Case of New-onset AI-associated Psychosis

Due to the timely nature of this topic, we are providing an advanced release of this article, ahead of the October-December 2025 issue publication. This article is subject to changes

Letter to the Editor: A Report of Early-onset Psychosis Occurring in the Context of a Perinatal Stroke History

Dear Editor: Although poststroke psychosis is a reasonably well-established clinical phenomenon,1 few articles describing the development of psychotic symptoms on the background of a perinatal stroke history or other anoxic

Letter to the Editor: A First Seizure After 2,000mg Fluoxetine May or May Not Be Due to Intoxication

Dear Editor: I read with interest the article by Allen et al1 about a 19-year-old male transgender patient who developed seizures after intentionally taking 2,000mg of fluoxetine. His medical history